As of 21:15 ET (21:15 GMT), Brent Oil Futures expiring in August edged down 0.4% to $93.80 per barrel, while West Texas Intermediate ( WTI) crude futures also fell 0.5% $90.86 per barrel.

Investing.com-- Gold prices were little changed in Asian trade on Tuesday, hovering near an 11-week low, as a halt in ...

Iran kept the Strait of Hormuz largely blocked amid continued hostilities with the U.S. and Israel, helping underpin oil ...

UBS raised its 12-month price target 16% to €50 per share from €43, reflecting a new price deck and updated guidance, but ...

Adjusted earnings per share for Honeywell Technologies is projected to be $3.95 to $4.15 in 2026, representing growth of 22% ...

On currency markets, the British pound has shown resilience since the start of the conflict in the Middle East, with EUR/GBP trading in narrow ranges. UBS targets 0.8750 for end-Q2 and 0.8500 for year ...

Moody’s Ratings affirmed ZoomInfo Technologies Inc.’s Ba3 corporate family rating and Ba3-PD probability of default rating today. The firm also affirmed ZoomIn ...

UBS has taken a more cautious view on the US restaurant sector for the second half of 2026, warning that weak consumer demand, high gasoline prices and poor senti ...

Jones Trading analyst Catherine Novack initiated coverage on Spruce Biosciences with a buy rating and a price target of $135. The firm cited the potential approval of TA-ERT in mid-2027 and near-term ...

The Board appointed Albert A. Manzone, a current board member, as Interim President and CEO and initiated a search for a ...

Ideaya Biosciences Inc (NASDAQ:IDYA) shares dropped 7.9% in after-hours trading Monday after the company announced plans for a $300 million public offering of com ...

Investing.com--AstraZeneca PLC ( LON:AZN) is advancing its oral GLP-1 receptor agonist elecoglipron into a Phase III clinical program after two mid-stage trials demonstrated meaningful weight loss and ...